Aplaviroc is a potent and selective CCR5 antagonist used to study HIV-1 infection mechanisms. It effectively inhibits viral strains including Ba-L, JRFL, and MOKW in vitro and has been investigated in clinical trials for antiviral therapy. This small molecule is a valuable research tool for exploring HIV entry inhibition and CCR5 receptor function.
Molekulargewicht:
577.71
Reinheit:
99.53% (May vary between batches)
CAS Nummer:
[461443-59-4]
Formel:
C33H43N3O6
Target-Kategorie:
HIV Protease,CCR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten